152 related articles for article (PubMed ID: 33570867)
1. The Role of Predictive Biomarkers in Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
Bosse T; Lax S; Abu-Rustum N; Matias-Guiu X
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S102-S110. PubMed ID: 33570867
[TBL] [Abstract][Full Text] [Related]
2. Tumor Typing of Endocervical Adenocarcinoma: Contemporary Review and Recommendations From the International Society of Gynecological Pathologists.
Stolnicu S; Park KJ; Kiyokawa T; Oliva E; McCluggage WG; Soslow RA
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S75-S91. PubMed ID: 33570865
[TBL] [Abstract][Full Text] [Related]
3. Tumor Staging of Endocervical Adenocarcinoma: Recommendations From the International Society of Gynecological Pathologists.
Park KJ; Roma A; Singh N; Gilks CB; Oliva E; Abu-Rustum N; Ramirez PT; McCluggage WG
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S92-S101. PubMed ID: 33570866
[TBL] [Abstract][Full Text] [Related]
4. The Silva Pattern-based Classification for HPV-associated Invasive Endocervical Adenocarcinoma and the Distinction Between In Situ and Invasive Adenocarcinoma: Relevant Issues and Recommendations From the International Society of Gynecological Pathologists.
Alvarado-Cabrero I; Parra-Herran C; Stolnicu S; Roma A; Oliva E; Malpica A
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S48-S65. PubMed ID: 33570863
[TBL] [Abstract][Full Text] [Related]
5. An analysis of HER2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
Shi H; Shao Y; Lu W; Lu B
J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
[TBL] [Abstract][Full Text] [Related]
6. Online Training and Self-assessment in the Histopathologic Classification of Endocervical Adenocarcinoma and Diagnosis of Pattern of Invasion: Evaluation of Participant Performance.
Park KJ; Cabrero IA; Fadare O; Hoang L; Kiyokawa T; Oliva E; Parra-Herran C; Rabban JT; Roma A; Singh N; Soslow R; Stolnicu S; Huvila J; Leung S; Gilks CB
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S14-S23. PubMed ID: 33570861
[TBL] [Abstract][Full Text] [Related]
7. Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy.
Cho WK; Kim HS; Park W; Chang CS; Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG
J Gynecol Oncol; 2022 Nov; 33(6):e71. PubMed ID: 36047374
[TBL] [Abstract][Full Text] [Related]
8. Molecular and pathological basis of HPV-negative cervical adenocarcinoma seen in a global study.
Jenkins D; Molijn A; Kazem S; Pirog EC; Alemany L; de Sanjosé S; Dinjens W; Quint W
Int J Cancer; 2020 Nov; 147(9):2526-2536. PubMed ID: 32474915
[TBL] [Abstract][Full Text] [Related]
9. Programmed death-ligand 1 expression in human papillomavirus-independent cervical adenocarcinoma and its prognostic significance.
Chen L; Lucas E; Zhang X; Liu Q; Zhuang Y; Lin W; Chen H; Zhou F
Histopathology; 2022 Jan; 80(2):338-347. PubMed ID: 34455625
[TBL] [Abstract][Full Text] [Related]
10. HES1 Protein Modulates Human Papillomavirus-Mediated Carcinoma of the Uterine Cervix.
Tripathi R; Rath G; Sharma V; Hussain S; Sharma S; Bharadwaj M; Mehrotra R
J Glob Oncol; 2019 Jan; 5():1-10. PubMed ID: 30615540
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women.
Yang-Chun F; Sen-Yu W; Yuan Z; Yan-Chun H
J Immunol Res; 2020; 2020():6284960. PubMed ID: 32411801
[TBL] [Abstract][Full Text] [Related]
12. Endocervical Adenocarcinoma With Morphologic Features of Both Usual and Gastric Types: Clinicopathologic and Immunohistochemical Analyses and High-risk HPV Detection by In Situ Hybridization.
Wada T; Ohishi Y; Kaku T; Aman M; Imamura H; Yasutake N; Sonoda K; Kato K; Oda Y
Am J Surg Pathol; 2017 May; 41(5):696-705. PubMed ID: 28296678
[TBL] [Abstract][Full Text] [Related]
13. Expressions of programmed death (PD)-1 and PD-1 ligand (PD-L1) in cervical intraepithelial neoplasia and cervical squamous cell carcinomas are of prognostic value and associated with human papillomavirus status.
Yang W; Lu YP; Yang YZ; Kang JR; Jin YD; Wang HW
J Obstet Gynaecol Res; 2017 Oct; 43(10):1602-1612. PubMed ID: 28833798
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and attribution of high-risk HPV in different histological types of cervical cancer].
Wang WP; An JS; Yao HW; Li N; Zhang YY; Ge L; Song Y; Wang MJ; Yuan GW; Sun YC; Huang MN; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):293-300. PubMed ID: 31154709
[No Abstract] [Full Text] [Related]
15. [Distribution of human papillomavirus (HPV) among HPV positive cervical adenocarcinoma cases detected by laser capture microdissection(LCM)].
Liu B; Wu ZN; Liu XY; Sun HK; Li Q; Lin CQ; Zeng L; Cui JF; Yu XH; Zhang X; Li L; Chen W
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):277-82. PubMed ID: 27087374
[TBL] [Abstract][Full Text] [Related]
16. Endocervical Adenocarcinoma, Gross Examination, and Processing, Including Intraoperative Evaluation: Recommendations From the International Society of Gynecological Pathologists.
Parra-Herran C; Malpica A; Oliva E; Zannoni GF; Ramirez PT; Rabban JT
Int J Gynecol Pathol; 2021 Mar; 40(Suppl 1):S24-S47. PubMed ID: 33570862
[TBL] [Abstract][Full Text] [Related]
17. Cytological screening of endocervical adenocarcinoma.
Di Bonito L; Bergeron C
Ann Pathol; 2012 Dec; 32(6):e8-14, 394-400. PubMed ID: 23244488
[TBL] [Abstract][Full Text] [Related]
18. Association between PD-L1 and HPV status and the prognostic value for HPV treatment in premalignant cervical lesion patients.
Yang-Chun F; Zhen-Zhen C; Yan-Chun H; Xiu-Min M
Medicine (Baltimore); 2017 Jun; 96(25):e7270. PubMed ID: 28640134
[TBL] [Abstract][Full Text] [Related]
19. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.
Chen W; Molijn A; Enqi W; Zhang X; Jenkins D; Yu X; Quint W; Schmidt JE; Li J; Pirog E; Liu B; Li Q; Liu X; Li L; Qiao Y;
Int J Cancer; 2016 Dec; 139(12):2687-2697. PubMed ID: 27554015
[TBL] [Abstract][Full Text] [Related]
20. FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
Stolnicu S; Boros M; Hoang L; Almadani N; de Brot L; Baiocchi G; Bonvolim G; Parra-Herran C; Lerias S; Felix A; Roma A; Pesci A; Oliva E; Park K; Soslow RA; Abu-Rustum NR
Int J Gynecol Cancer; 2021 Feb; 31(2):177-184. PubMed ID: 33177150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]